Aveo Capital Partners LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 68.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 543 shares of the healthcare conglomerate's stock after selling 1,169 shares during the quarter. Aveo Capital Partners LLC's holdings in UnitedHealth Group were worth $284,000 as of its most recent filing with the SEC.
Other large investors also recently bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $26,000. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the period. Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $41,000. Copia Wealth Management bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $42,000. Finally, IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at approximately $42,000. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
Shares of UnitedHealth Group stock opened at $250.74 on Monday. The company has a market capitalization of $227.46 billion, a PE ratio of 10.86, a PEG ratio of 1.62 and a beta of 0.43. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock's fifty day simple moving average is $291.78 and its 200 day simple moving average is $405.18.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the business posted $6.80 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.5%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio is presently 38.30%.
Wall Street Analysts Forecast Growth
UNH has been the subject of several recent research reports. TD Securities reaffirmed a "hold" rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Truist Financial cut their price target on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Hold" and a consensus price target of $366.52.
Read Our Latest Stock Analysis on UnitedHealth Group
Insider Buying and Selling
In other news, Director Kristen Gil purchased 3,700 shares of the business's stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.